NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis $0.04 -0.01 (-15.77%) As of 03:23 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock About Acutus Medical Stock (NASDAQ:AFIB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Acutus Medical alerts:Sign Up Key Stats Today's Range$0.04▼$0.0550-Day Range$0.04▼$0.0752-Week Range$0.03▼$0.22Volume128,836 shsAverage Volume39,384 shsMarket Capitalization$1.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Read More… Remove Ads Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AFIB Stock News HeadlinesAcutus Medical Reports Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.April 4, 2025 | Priority Gold (Ad)Acutus Medical Reports Q3 2024 Financial ResultsNovember 20, 2024 | markets.businessinsider.comStudy reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutterNovember 14, 2024 | msn.comAcutus Medical Reports Third Quarter and Year-To-Date 2024 Financial ResultsNovember 14, 2024 | globenewswire.comExtra hour of weekly exercise reduces risk of atrial fibrillationNovember 12, 2024 | msn.comThe Apple Watch is helping Afib patients ditch blood thinners in a ground-breaking trialNovember 8, 2024 | msn.comSee More Headlines AFIB Stock Analysis - Frequently Asked Questions How have AFIB shares performed this year? Acutus Medical's stock was trading at $0.0550 at the beginning of 2025. Since then, AFIB shares have decreased by 29.1% and is now trading at $0.0390. View the best growth stocks for 2025 here. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The business earned $4.60 million during the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%. Does Acutus Medical have any subsidiaries? Acutus Medical subsidiaries include Acutus Medical N.V.. When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto Group (RIO). Company Calendar Last Earnings11/11/2021Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:AFIB CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees340Year Founded2011Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-81,660,000.00 Net Margins-272.74% Pretax Margin-30.32% Return on Equity-311.64% Return on Assets-11.57% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.57 Sales & Book Value Annual Sales$7.16 million Price / Sales0.16 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-1.30Miscellaneous Outstanding Shares29,779,000Free Float28,228,000Market Cap$1.16 million OptionableOptionable Beta-0.13 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:AFIB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.